Analyze Diet
Frontiers in veterinary science2019; 6; 414; doi: 10.3389/fvets.2019.00414

Radio-Telemetric Assessment of Cardiac Variables and Locomotion With Experimentally Induced Hypermagnesemia in Horses Using Chronically Implanted Catheters.

Abstract: The objective of this study was to characterize the pharmacokinetics and pharmacodynamics of intravenous administration of magnesium sulfate to horses using a novel radio-telemetry system for physiologic signal capture. Five Horses were surgically implanted with a radio-telemetric carotid catheter. Implants were paired with a non-invasive telemetric unit which acquired a six lead ECG and 3-axis acceleration to assess activity acquired wirelessly in real-time for future analysis. Horses were exposed to a new stall environment before (baseline) and after 60 mg/kg (30 mL) of magnesium sulfate (MgSO), or the same volume of 0.9% saline, administered intravenously in a blinded, random crossover design. Blood for pharmacokinetics, telemetric data, and body temperature were recorded serially for 24 h. Data were analyzed across time and between treatments. Significance was set at < 0.05. Ionized magnesium concentration (Mg) increased and the Ca to Mg ratio decreased and persisted for 5 h after MgSO administration. Heart rate (HR) increased and mean arterial blood pressure (MAP) decreased for at least 6 h. Electrocardiogram (ECG) intervals (RR) decreased and (PR and QTc) increased in duration compared to controls indicating an increase in heart rate, and slower myocardial conduction in the MgSO group. Acceleration in all planes was less in the MgSO group compared to controls indicating decreased locomotion. This novel method permitted collection of physiologic signals without interference by handlers or animal restraint. An intravenous bolus of MgSO produced cardiac variable changes associated with the reduction of locomotion in these horses, and in a direction that may be causal. Locomotion was decreased when horses were first introduced into a new environment which reflects the calming effect desired in sport horses. Telemetric monitoring can be used as a model to elucidate the behavior and physiologic effects of other drugs. The administration of MgSO may be detected for regulatory purposes with the monitoring of Mg and Ca concentrations and their ratio.
Publication Date: 2019-11-21 PubMed ID: 31850378PubMed Central: PMC6881382DOI: 10.3389/fvets.2019.00414Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents a study assessing the impact of magnesium sulfate administration on horse heart rate and movement, using a newly developed radio-telemetry system for live, non-invasive monitoring. The study shows that magnesium sulfate injection alters cardiac functions and reduces horse locomotion, reflecting potential calming effects sought in sports horses.

Introduction

  • The research aimed to investigate the effects of intravenous magnesium sulfate administration in horses, using a novel radio-telemetry system to understand heart rate and movement in real time.
  • Radio-telemetry allows for remote, continuous, real-time physiological data collection, reducing direct human-horse interaction and possible bias due to handler-induced stress.

Method

  • Five horses were implanted with a catheter and linked to a non-invasive telemetric recording unit to monitor cardiac variables and locomotion wirelessly.
  • The horses were exposed to a new environment and were given 60 mg/kg of magnesium sulfate intravenously, or an equivalent amount of saline, in a random, blinded test.
  • Data collected included ionized magnesium concentration, heart rate, arterial blood pressure, Electrocardiogram (ECG) intervals, and movement levels.

Results & Findings

  • Results showed that after magnesium sulfate administration, the ionized magnesium concentration increased, while the ratio of calcium to magnesium decreased, suggesting an alteration in mineral balance within the body.
  • Cardiac measurements showed an increased heart rate and a decrease in arterial blood pressure for at least 6 hours. Additional ECG measurements also suggested a slowing of myocardial conduction.
  • The horses exhibited less motion in all directions, suggesting a decrease in locomotion following the magnesium sulfate administration.

Implications & Conclusion

  • This study demonstrated that the administration of magnesium sulfate can alter cardiac variables and reduce horse locomotion, highlighting potential calming effects sought in sports horses.
  • Also, the study showcases how real-time telemetric monitoring can provide comprehensive insights into drug-induced behavioral and physiological changes in animals.
  • Lastly, by monitoring magnesium and calcium concentrations and their ratio, the administration of magnesium sulfate can be tracked for regulatory purposes.

Cite This Article

APA
Schumacher SA, Toribio RE, Lakritz J, Bertone AL. (2019). Radio-Telemetric Assessment of Cardiac Variables and Locomotion With Experimentally Induced Hypermagnesemia in Horses Using Chronically Implanted Catheters. Front Vet Sci, 6, 414. https://doi.org/10.3389/fvets.2019.00414

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 6
Pages: 414
PII: 414

Researcher Affiliations

Schumacher, Stephen A
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States.
  • The United States Equestrian Federation, Equine Drugs and Medications Program, Columbus, OH, United States.
Toribio, Ramiro E
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States.
Lakritz, Jeffrey
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States.
Bertone, Alicia L
  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, United States.

References

This article includes 48 references
  1. Baus M. Quieting With Magnesium Sulfate. USHJA In Stride August edn. (2010).
  2. Teragawa H, Matsuura H, Chayama K, Oshima T. Mechanisms responsible for vasodilation upon magnesium infusion in vivo: clinical evidence.. Magnes Res 2002 Dec;15(3-4):241-6.
    pubmed: 12635879
  3. Easterling T, Hebert M, Bracken H, Darwish E, Ramadan MC, Shaarawy S, Charles D, Abdel-Aziz T, Nasr AS, Safwal SM, Winikoff B. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion.. BMC Pregnancy Childbirth 2018 Jul 6;18(1):290.
    doi: 10.1186/s12884-018-1919-6pmc: PMC6034206pubmed: 29976161google scholar: lookup
  4. Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and Current Clinical Management of Preeclampsia.. Curr Hypertens Rep 2017 Aug;19(8):61.
    doi: 10.1007/s11906-017-0757-7pmc: PMC5916784pubmed: 28689331google scholar: lookup
  5. Chiarello DI, Marín R, Proverbio F, Coronado P, Toledo F, Salsoso R, Gutiérrez J, Sobrevia L. Mechanisms of the effect of magnesium salts in preeclampsia.. Placenta 2018 Sep;69:134-139.
  6. Clerc P, Young CA, Bordt EA, Grigore AM, Fiskum G, Polster BM. Magnesium sulfate protects against the bioenergetic consequences of chronic glutamate receptor stimulation.. PLoS One 2013;8(11):e79982.
  7. Lord MS, Augoustides JG. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin.. J Cardiothorac Vasc Anesth 2012 Jun;26(3):526-31.
    doi: 10.1053/j.jvca.2012.01.002pubmed: 22361482google scholar: lookup
  8. Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department.. Cochrane Database Syst Rev 2014 May 28;(5):CD010909.
    doi: 10.1002/14651858.CD010909pubmed: 24865567google scholar: lookup
  9. Su Z, Li R, Gai Z. Intravenous and Nebulized Magnesium Sulfate for Treating Acute Asthma in Children: A Systematic Review and Meta-Analysis.. Pediatr Emerg Care 2018 Jun;34(6):390-395.
    doi: 10.1097/PEC.0000000000000909pubmed: 29851914google scholar: lookup
  10. Becker SM, Job KM, Lima K, Forbes TJ, Wagstaff J, Tran NK, Sherwin CM, Nelson DS, Johnson MD, Rower JE. Prospective study of serum and ionized magnesium pharmacokinetics in the treatment of children with severe acute asthma.. Eur J Clin Pharmacol 2019 Jan;75(1):59-66.
    doi: 10.1007/s00228-018-2557-7pubmed: 30259065google scholar: lookup
  11. Lopes MA, Walker BL, White NA 2nd, Ward DL. Treatments to promote colonic hydration: enteral fluid therapy versus intravenous fluid therapy and magnesium sulphate.. Equine Vet J 2002 Jul;34(5):505-9.
    doi: 10.2746/042516402776117782pubmed: 12358055google scholar: lookup
  12. Lopes MA, White NA 2nd, Donaldson L, Crisman MV, Ward DL. Effects of enteral and intravenous fluid therapy, magnesium sulfate, and sodium sulfate on colonic contents and feces in horses.. Am J Vet Res 2004 May;65(5):695-704.
    doi: 10.2460/ajvr.2004.65.695pubmed: 15141893google scholar: lookup
  13. Sheldon SA, Aleman M, Costa LRR, Santoyo AC, Howey Q, Madigan JE. Intravenous infusion of magnesium sulfate and its effect on horses with trigeminal-mediated headshaking.. J Vet Intern Med 2019 Mar;33(2):923-932.
    doi: 10.1111/jvim.15410pmc: PMC6430935pubmed: 30666732google scholar: lookup
  14. Schumacher SA, Yardley J, Bertone AL. Ionized magnesium and calcium concentration and their ratio in equine plasma samples as determined by a regulatory laboratory compared to a clinical reference laboratory.. Drug Test Anal 2019 Mar;11(3):455-460.
    doi: 10.1002/dta.2509pubmed: 30253069google scholar: lookup
  15. Kim SH, Lilot M, Sidhu KS, Rinehart J, Yu Z, Canales C, Cannesson M. Accuracy and precision of continuous noninvasive arterial pressure monitoring compared with invasive arterial pressure: a systematic review and meta-analysis.. Anesthesiology 2014 May;120(5):1080-97.
    doi: 10.1097/ALN.0000000000000226pubmed: 24637618google scholar: lookup
  16. Kristal-Boneh E, Melamed S, Bernheim J, Peled I, Green MS. Reduced ambulatory heart rate response to physical work and complaints of fatigue among hypertensive males treated with beta-blockers.. J Behav Med 1995 Apr;18(2):113-26.
    doi: 10.1007/BF01857864pubmed: 7563041google scholar: lookup
  17. Wong GW, Boyda HN, Wright JM. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.. Cochrane Database Syst Rev 2016 Mar 10;3(3):CD007451.
  18. Sica DA, Neutel JM, Weber MA, Manowitz N. The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension.. J Clin Hypertens (Greenwich) 2004 May;6(5):231-41.
  19. Gauvin DV, Tilley LP, Smith FW Jr, Baird TJ. Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving laboratory beagle dog by remote radiotelemetry.. J Pharmacol Toxicol Methods 2006 Mar-Apr;53(2):128-39.
    doi: 10.1016/j.vascn.2005.11.004pubmed: 16380274google scholar: lookup
  20. Soloviev MV, Hamlin RL, Shellhammer LJ, Barrett RM, Wally RA, Birchmeier PA, Schaefer GJ. Variations in hemodynamic parameters and ECG in healthy, conscious, freely moving telemetrized beagle dogs.. Cardiovasc Toxicol 2006;6(1):51-62.
    doi: 10.1385/CT:6:1:51pubmed: 16845182google scholar: lookup
  21. Chaves AA, Zingaro GJ, Yordy MA, Bustard KA, O'Sullivan S, Galijatovic-Idrizbegovic A, Schuck H, Christian DB, Hoe CM, Briscoe RJ. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.. J Pharmacol Toxicol Methods 2007 Sep-Oct;56(2):103-14.
    doi: 10.1016/j.vascn.2007.04.007pubmed: 17643323google scholar: lookup
  22. Saengklub N, Youngblood B, Del Rio C, Sawangkoon S, Hamlin RL, Kijtawornrat A. Short-term effects of oral dronedarone administration on cardiac function, blood pressure and electrocardiogram in conscious telemetry dogs.. J Vet Med Sci 2016 Jul 1;78(6):977-85.
    doi: 10.1292/jvms.15-0481pmc: PMC4937158pubmed: 26922916google scholar: lookup
  23. Ricco CH, Quandt JE, Novo RE, Killos M, Graham L. Use of a wireless system to measure invasive arterial blood pressure in ponies - preliminary study.. Vet Anaesth Analg 2009 Jan;36(1):1-8.
  24. Nakayama T, Nakayama H, Miyamoto M, Hamlin RL. Hemodynamic and electrocardiographic effects of magnesium sulfate in healthy dogs.. J Vet Intern Med 1999 Sep-Oct;13(5):485-90.
  25. Honarmand A, Safavi M, Badiei S, Daftari-Fard N. Different doses of intravenous Magnesium sulfate on cardiovascular changes following the laryngoscopy and tracheal intubation: A double-blind randomized controlled trial.. J Res Pharm Pract 2015 Apr-Jun;4(2):79-84.
    doi: 10.4103/2279-042X.154365pmc: PMC4418140pubmed: 25984545google scholar: lookup
  26. Zhang J, Wang Y, Xu H, Yang J. Influence of magnesium sulfate on hemodynamic responses during laparoscopic cholecystectomy: A meta-analysis of randomized controlled studies.. Medicine (Baltimore) 2018 Nov;97(45):e12747.
    doi: 10.1097/MD.0000000000012747pmc: PMC6250549pubmed: 30407279google scholar: lookup
  27. Standley CA, Batia L, Yueh G. Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia.. J Matern Fetal Neonatal Med 2006 Mar;19(3):171-6.
    doi: 10.1080/14767050500448005pubmed: 16690511google scholar: lookup
  28. Tang J, He A, Li N, Chen X, Zhou X, Fan X, Liu Y, Zhang M, Qi L, Tao J, Sun M, Xu Z. Magnesium Sulfate-Mediated Vascular Relaxation and Calcium Channel Activity in Placental Vessels Different From Nonplacental Vessels.. J Am Heart Assoc 2018 Jul 12;7(14).
    doi: 10.1161/JAHA.118.009896pmc: PMC6064843pubmed: 30005554google scholar: lookup
  29. Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels.. Can J Physiol Pharmacol 1987 Apr;65(4):729-45.
    doi: 10.1139/y87-120pubmed: 3300911google scholar: lookup
  30. Turlapaty PD, Altura BM. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle.. Eur J Pharmacol 1978 Dec 1;52(3-4):421-3.
    doi: 10.1016/0014-2999(78)90303-5pubmed: 729651google scholar: lookup
  31. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. Magnesium causes nitric oxide independent coronary artery vasodilation in humans.. Heart 2001 Aug;86(2):212-6.
    doi: 10.1136/heart.86.2.212pmc: PMC1729866pubmed: 11454846google scholar: lookup
  32. Hartzell HC, White RE. Effects of magnesium on inactivation of the voltage-gated calcium current in cardiac myocytes.. J Gen Physiol 1989 Oct;94(4):745-67.
    doi: 10.1085/jgp.94.4.745pmc: PMC2228970pubmed: 2559140google scholar: lookup
  33. Zhou Q, Shen J, Zhou G, Shen L, Zhou S, Li X. Effects of magnesium sulfate on heart rate, blood pressure variability and baroreflex sensitivity in preeclamptic rats treated with L-NAME.. Hypertens Pregnancy 2013 Nov;32(4):422-31.
    doi: 10.3109/10641955.2013.824978pubmed: 23957853google scholar: lookup
  34. Shimosawa T, Takano K, Ando K, Fujita T. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings.. Hypertension 2004 Dec;44(6):897-902.
  35. Mordes JP, Wacker WE. Excess magnesium.. Pharmacol Rev 1977 Dec;29(4):273-300.
    pubmed: 364497
  36. Akazawa S, Shimizu R, Nakaigawa Y, Ishii R, Ikeno S, Yamato R. Effects of magnesium sulphate on atrioventricular conduction times and surface electrocardiogram in dogs anaesthetized with sevoflurane.. Br J Anaesth 1997 Jan;78(1):75-80.
    doi: 10.1093/bja/78.1.75pubmed: 9059208google scholar: lookup
  37. Rasmussen HS, Thomsen PE. The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle.. Clin Cardiol 1989 Feb;12(2):85-90.
    doi: 10.1002/clc.4960120204pubmed: 2653679google scholar: lookup
  38. Nonaka M, Ondrovic LE, Schultz SM, McKeown PP. Electrocardiographic changes after intravenous administration of magnesium in rabbits.. Lab Anim Sci 1996 Aug;46(4):434-7.
    pubmed: 8872996
  39. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S. Treatment of torsade de pointes with magnesium sulfate.. Circulation 1988 Feb;77(2):392-7.
    doi: 10.1161/01.CIR.77.2.392pubmed: 3338130google scholar: lookup
  40. Tzivoni D, Keren A, Cohen AM, Loebel H, Zahavi I, Chenzbraun A, Stern S. Magnesium therapy for torsades de pointes.. Am J Cardiol 1984 Feb 1;53(4):528-30.
    doi: 10.1016/0002-9149(84)90025-0pubmed: 6695782google scholar: lookup
  41. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium.. Am J Cardiol 1990 Jun 1;65(20):1397-9.
    doi: 10.1016/0002-9149(90)91335-4pubmed: 2188497google scholar: lookup
  42. Keren A, Tzivoni D. Magnesium therapy in ventricular arrhythmias.. Pacing Clin Electrophysiol 1990 Jul;13(7):937-45.
  43. Sugiyama A, Xue Yx, Hagihara A, Saitoh M, Hashimoto K. Characterization of Magnesium Sulfate as an Antiarrhythmic Agent.. J Cardiovasc Pharmacol Ther 1996 Jul;1(3):243-254.
    pubmed: 10684423doi: 10.1177/107424849600100308google scholar: lookup
  44. Wu JY, Lipsius SL. Effects of extracellular Mg2+ on T- and L-type Ca2+ currents in single atrial myocytes.. Am J Physiol 1990 Dec;259(6 Pt 2):H1842-50.
  45. Pedersen PJ, Kanters JK, Buhl R, Klaerke DA. Normal electrocardiographic QT interval in race-fit Standardbred horses at rest and its rate dependence during exercise.. J Vet Cardiol 2013 Mar;15(1):23-31.
    doi: 10.1016/j.jvc.2012.08.002pubmed: 23434174google scholar: lookup
  46. DiCarlo LA Jr, Morady F, de Buitleir M, Krol RB, Schurig L, Annesley TM. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans.. J Am Coll Cardiol 1986 Jun;7(6):1356-62.
    doi: 10.1016/S0735-1097(86)80157-7pubmed: 3711493google scholar: lookup
  47. Biesenbach P, Mårtensson J, Lucchetta L, Bangia R, Fairley J, Jansen I, Matalanis G, Bellomo R. Pharmacokinetics of Magnesium Bolus Therapy in Cardiothoracic Surgery.. J Cardiothorac Vasc Anesth 2018 Jun;32(3):1289-1294.
    doi: 10.1053/j.jvca.2017.08.049pubmed: 29169799google scholar: lookup
  48. Biesenbach P, Mårtensson J, Osawa E, Eastwood G, Cutuli S, Fairley J, Matalanis G, Bellomo R. Magnesium supplementation: Pharmacokinetics in cardiac surgery patients with normal renal function.. J Crit Care 2018 Apr;44:419-423.
    doi: 10.1016/j.jcrc.2018.01.011pubmed: 29353118google scholar: lookup

Citations

This article has been cited 1 times.
  1. Schumacher SA, Kamr AM, Lakritz J, Burns TA, Bertone AL, Toribio RE. Effects of intravenous magnesium sulfate on serum calcium-regulating hormones and plasma and urinary electrolytes in healthy horses. PLoS One 2021;16(6):e0247542.
    doi: 10.1371/journal.pone.0247542pubmed: 34181644google scholar: lookup